...
首页> 外文期刊>Nutrition Reviews >A novel, enigmatic histone modification: biotinylation of histones by holocarboxylase synthetase
【24h】

A novel, enigmatic histone modification: biotinylation of histones by holocarboxylase synthetase

机译:一种新颖的,神秘的组蛋白修饰:全羧化酶合成酶对组蛋白进行生物素化

获取原文
获取原文并翻译 | 示例
           

摘要

Holocarboxylase synthetase catalyzes the covalent binding of biotin to histones in humans and other eukaryotes. Eleven biotinylation sites have been identified in histones H2A, H3, and H4. K12-biotinylated histone H4 is enriched in heterochromatin, repeat regions, and plays a role in gene repression. About 30% of the histone H4 molecules are biotinylated at K12 in histone H4 in human fibroblast telomeres. The abundance of biotinylated histones at distinct genomic loci depends on biotin availability. Decreased histone biotinylation decreases life span and stress resistance in Drosophila. Low enrichment of biotinylated histones at transposable elements impairs repression of these elements.
机译:全息羧化酶合成酶催化生物素与人和其他真核生物中组蛋白的共价结合。在组蛋白H2A,H3和H4中已鉴定出11个生物素化位点。 K12生物素化的组蛋白H4富含异染色质,重复区域,并在基因阻抑中起作用。在人类成纤维细胞端粒中,约30%的组蛋白H4分子在组蛋白H4的K12处被生物素化。不同基因组位点上生物素化组蛋白的丰度取决于生物素的可用性。组蛋白生物素化的减少会降低果蝇的寿命和抗逆性。转座因子中生物素化组蛋白的富集度低会削弱这些元素的阻抑作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号